Rebecca L. Ashare

ORCID: 0000-0003-4664-009X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Smoking Behavior and Cessation
  • Nicotinic Acetylcholine Receptors Study
  • Behavioral Health and Interventions
  • Cannabis and Cannabinoid Research
  • Eating Disorders and Behaviors
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • HIV/AIDS Research and Interventions
  • Stress Responses and Cortisol
  • Tryptophan and brain disorders
  • HIV-related health complications and treatments
  • Biochemical Analysis and Sensing Techniques
  • Olfactory and Sensory Function Studies
  • HIV Research and Treatment
  • Bariatric Surgery and Outcomes
  • Religion, Spirituality, and Psychology
  • Sleep and related disorders
  • Neural and Behavioral Psychology Studies
  • Mental Health Research Topics
  • Functional Brain Connectivity Studies
  • Coffee research and impacts
  • Pain Management and Opioid Use
  • Bipolar Disorder and Treatment
  • Homelessness and Social Issues
  • HIV, Drug Use, Sexual Risk
  • Psychological and Temporal Perspectives Research

University at Buffalo, State University of New York
2007-2025

New York University
2025

University of Pennsylvania
2015-2024

Buffalo State University
2023

Philadelphia University
2005-2018

Yale University
2011

Increased preference for immediate over delayed rewards and risky certain has been associated with unhealthy behavioral choices. Motivated by evidence that enhanced cognitive control can shift choice behavior away from rewards, we tested whether training executive function could influence brain responses. In this randomized controlled trial, 128 young adults (71 male, 57 female) participated in 10 weeks of either a commercial web-based program or video games do not specifically target adapt...

10.1523/jneurosci.2832-16.2017 article EN Journal of Neuroscience 2017-07-10

Abstract Background and aims Mechanisms of varenicline preloading in promoting smoking abstinence have not been evaluated. Based on an extinction reinforcement framework, we tested the hypothesis that pre‐quit reductions rate mediate effect extended abstinence. We also alternative indicators change reinforcement, as well aversion, nausea self‐efficacy candidate mediators. Design, participants intervention Randomized, double‐blind, placebo‐controlled trial (NCT03262662) comparing (4‐week...

10.1111/add.16772 article EN Addiction 2025-02-06

Stress and prefrontal cognitive dysfunction have key roles in driving smoking; however, there are no therapeutics for smoking cessation that attenuate the effects of stress on enhance cognition. Central noradrenergic pathways involved stress-induced reinstatement to nicotine executive control adaptive behaviors. We used a novel translational approach employing validated laboratory analogue stress-precipitated smoking, functional magnetic resonance imaging (fMRI), proof-of-concept treatment...

10.1177/0269881114562091 article EN Journal of Psychopharmacology 2014-12-16

Abstract Background: As part of the Family Smoking Prevention and Tobacco Control Act, U.S. Food Drug Administration charged Products Scientific Advisory Committee with developing a report recommendations about effect menthol in cigarettes on public health. The purpose this study was to examine smoking behaviors, biomarkers exposure, subjective responses when switching from novel cigarette non-menthol isolate approximate ban might have smokers. Methods: Thirty-two adult smokers completed...

10.1158/1055-9965.epi-12-1097 article EN Cancer Epidemiology Biomarkers & Prevention 2013-01-19

HIV-infected smokers lose more life years to tobacco use than HIV infection. The nicotine metabolite ratio (NMR), a biomarker of CYP2A6, represents individual variation in the rate at which is metabolized and associated with response smoking cessation treatments. We evaluated whether metabolize faster HIV-uninfected smokers, may contribute disproportionate burden have important treatment implications.We analysed baseline data from two clinical trials (NCT01710137; NCT01314001) compare NMR (N...

10.1097/qad.0000000000002127 article EN AIDS 2019-01-16

There is a critical need for the development of novel treatments nicotine dependence. Because majority smokers who make quit attempt fail within 7 days, medication screening procedures that focus on this early cessation period may provide an indicator treatment efficacy. To establish clinical validity paradigm, it to demonstrate association abstinence with longer-term abstinence. We tested number days during first week after target date (TQD) as predictor point prevalence in 3 independent...

10.1097/adm.0b013e31829363e1 article EN Journal of Addiction Medicine 2013-05-11

Abstract Background The legal climate for cannabis use has dramatically changed with an increasing number of states passing legislation legalizing access medical and recreational use. Among cancer patients, is often used to ameliorate adverse effects treatment. Data are limited on the extent type among patients during treatment perceived benefits harms. This multicenter survey was conducted assess residing in varied cannabis. Methods A total 12 NCI-Designated Cancer Centers, across...

10.1093/jncimonographs/lgae029 article EN public-domain JNCI Monographs 2024-08-01

An abstract is not available for this content so a preview has been provided. As you have access to content, full PDF via the 'Save PDF' action button.

10.1017/cts.2025.10 article EN cc-by-nc-nd Journal of Clinical and Translational Science 2025-01-30

Preclinical research and learning theory suggest that a longer duration of varenicline treatment prior to the target quit date (TQD) would reduce smoking rates before cessation improve abstinence outcomes. A double-blind randomized controlled trial tested this hypothesis in 60 smokers either an Extended run-in group (4 weeks pre-TQD varenicline) or Standard (3 placebo, 1 week varenicline); all participants received 11 post-TQD brief counseling. During pre-quit run-in, reduction was greater...

10.1038/clpt.2011.317 article EN Clinical Pharmacology & Therapeutics 2011-11-30

Introduction: The nicotine–metabolite ratio (NMR) predicts treatment response and is related to side effect severity. Sleep disturbance may be one important effect, but understanding sleep effects on smoking cessation complicated by the fact that nicotine withdrawal also produces disturbance. Aims: To evaluate of Methods: This a secondary analysis data from clinical trial (Lerman et al., 2015) 1,136 smokers randomised placebo ( n = 363), transdermal (TN; 381), or varenicline 392) stratified...

10.1017/jsc.2016.11 article EN The Journal of Smoking Cessation 2016-04-12
Coming Soon ...